Saturday, October 31, 2026

Match Group, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 14, 2020

Match Group, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Match Group, Inc.

18.9% sales growth and 47.72% return on equity

Match Group, Inc. sales growth this year is expected to be 16.6% and 18.5% for next year.

Year-on-year quarterly revenue growth grew by 18.1%, now sitting on 4.99B for the twelve trailing months.

Match Group, Inc.'s sales growth for the next quarter is 18.9%. The company's growth estimates for the current quarter and the next is 8.9% and negative -21.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.72%.

Match Group, Inc.'s Stock Top and Bottom Yearly Value

Match Group, Inc.'s stock is valued at $146.07 at 07:57 EST, under its 52-week high of $146.66 and way higher than its 52-week low of $35.58.

Match Group, Inc.'s Moving Average

Match Group, Inc.'s value is way higher than its 50-day moving average of $129.73 and way higher than its 200-day moving average of $107.42.

2. Alphabet

18.2% sales growth and 17.51% return on equity

Alphabet sales growth this year is anticipated to be 10.5% and 21.3% for next year.

Year-on-year quarterly revenue growth grew by 14%, now sitting on 171.7B for the twelve trailing months.

Alphabet's sales growth for the next quarter is 18.2%. The company's growth estimates for the ongoing quarter and the next is 1.9% and 38.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.51%.

Alphabet's Stock Top and Bottom Yearly Value

Alphabet's stock is valued at $1,774.80 at 07:57 EST, under its 52-week high of $1,843.83 and way higher than its 52-week low of $1,008.87.

Alphabet's Moving Average

Alphabet's worth is above its 50-day moving average of $1,726.12 and way higher than its 200-day moving average of $1,556.73.

3. Intuit Inc.

36.6% sales growth and 44.31% return on equity

Intuit Inc. sales growth this year is expected to be 15.4% and 15.2% for next year.

Year-on-year quarterly revenue growth grew by 13.6%, now sitting on 7.84B for the twelve trailing months.

Intuit Inc.'s sales growth for the next quarter is 36.6%. The company's growth estimates for the ongoing quarter and the next is 12.9% and 37.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 44.31%.

Intuit Inc.'s Stock Top and Bottom Yearly Value

Intuit Inc.'s stock is valued at $364.32 at 07:57 EST, below its 52-week high of $380.50 and way higher than its 52-week low of $187.68.

Intuit Inc.'s Moving Average

Intuit Inc.'s worth is higher than its 50-day moving average of $349.15 and way higher than its 200-day moving average of $320.09.

4. Applied Materials, Inc.

21.2% sales growth and 38.52% return on equity

Applied Materials, Inc. sales growth this year is expected to be 13.3% and 5.2% for next year.

Year-on-year quarterly revenue growth grew by 24.9%, now sitting on 17.2B for the twelve trailing months.

Applied Materials, Inc.'s sales growth for the next quarter is 21.2%. The company's growth estimates for the current quarter and the next is 28.6% and 36%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 38.52%.

Applied Materials, Inc.'s Stock Top and Bottom Yearly Value

Applied Materials, Inc.'s stock is valued at $88.30 at 07:57 EST, under its 52-week high of $90.26 and way above its 52-week low of $36.64.

Applied Materials, Inc.'s Moving Average

Applied Materials, Inc.'s worth is way higher than its 50-day moving average of $74.66 and way above its 200-day moving average of $64.40.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com